PHIO PHARMACEUTICALS CORP. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PHIO PHARMACEUTICALS CORP. (PHIO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 14.18 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- PHIO PHARMACEUTICALS CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 14.22M shares, a 112.43% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 6.69M shares, a 20.96% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 5.53M shares, a 794.92% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 618.33K shares, a 0.19% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 14.01M shares, a 601.04% increase from fiscal 2024.
- PHIO PHARMACEUTICALS CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 2.00M shares, a 64.10% decline from fiscal 2023.
- PHIO PHARMACEUTICALS CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 5.56M shares, a 838.53% increase from fiscal 2022.
- PHIO PHARMACEUTICALS CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 592.91K shares, a 2.90% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 14.18M shares 10-Q · filed 2026-08-06 | |||||||
| 2026-03-31 | 14.22M shares 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | 14.01M shares 10-K · filed 2026-03-05 | |||||||
| 2025-09-30 | 8.11M shares 10-Q · filed 2025-11-13 | |||||||
| 2025-06-30 | 6.67M shares 10-Q · filed 2026-08-06 | |||||||
| 2025-03-31 | 6.69M shares 10-Q · filed 2026-05-07 | |||||||
| 2024-12-31 | 2.00M shares 10-K · filed 2026-03-05 | |||||||
| 2024-09-30 | 1.27M shares 10-Q · filed 2025-11-13 | |||||||
| 2024-06-30 | 614.69K shares 10-Q · filed 2025-08-14 | |||||||
| 2024-03-31 | 5.53M shares 10-Q · filed 2025-05-15 | |||||||
| 2023-12-31 | 5.56M shares 10-K · filed 2025-03-31 | |||||||
| 2023-09-30 | 365.19K shares 10-Q · filed 2024-11-14 | 3.29M shares 10-Q · filed 2023-11-09 | ||||||
| 2023-06-30 | 365.58K shares 10-Q · filed 2024-08-14 | 3.29M shares 10-Q · filed 2023-08-10 | ||||||
| 2023-03-31 | 618.33K shares 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | 592.91K shares 10-K · filed 2024-04-01 | 592.87K shares 10-K · filed 2023-03-22 | ||||||
| 2022-09-30 | 602.56K shares 10-Q · filed 2023-11-09 | 7.23M shares 10-Q · filed 2022-11-10 | ||||||
| 2022-06-30 | 602.82K shares 10-Q · filed 2023-08-10 | 7.23M shares 10-Q · filed 2022-08-11 | ||||||
| 2022-03-31 | 619.51K shares 10-Q · filed 2023-05-11 | 7.43M shares 10-Q · filed 2022-05-12 | ||||||
| 2021-12-31 | 576.20K shares 10-K · filed 2023-03-22 | 6.91M shares 10-K · filed 2022-03-22 | ||||||
| 2021-09-30 | 6.94M shares 10-Q · filed 2022-11-10 | |||||||
| 2021-06-30 | 6.91M shares 10-Q · filed 2022-08-11 | |||||||
| 2021-03-31 | 6.91M shares 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | 3.59M shares 10-K · filed 2022-03-22 | |||||||
| 2020-09-30 | 3.59M shares 10-Q · filed 2021-11-10 | |||||||
| 2020-06-30 | 3.59M shares 10-Q · filed 2021-08-12 | |||||||
| 2020-03-31 | 3.16M shares 10-Q · filed 2021-05-13 | |||||||
| 2019-12-31 | 497.64K shares 10-K · filed 2021-03-25 | 497.63K shares 10-K · filed 2020-03-26 | ||||||
| 2019-09-30 | 499.62K shares 10-Q · filed 2020-11-10 | 27.48M shares 10-Q · filed 2019-11-12 | ||||||
| 2019-06-30 | 501.57K shares 10-Q · filed 2020-08-12 | 27.59M shares 10-Q · filed 2019-08-12 | ||||||
| 2019-03-31 | 528.24K shares 10-Q · filed 2020-05-12 | 29.05M shares 10-Q · filed 2019-05-14 | ||||||
| 2018-12-31 | 605.51K shares 10-K · filed 2020-03-26 | 33.30M shares 10-K · filed 2019-03-27 | ||||||
| 2018-09-30 | 3.00M shares 10-Q · filed 2019-11-12 | |||||||
| 2018-06-30 | 2.67M shares 10-Q · filed 2019-08-12 | |||||||
| 2018-03-31 | 1.46M shares 10-Q · filed 2019-05-14 | |||||||
| 2017-12-31 | 1.46M shares 10-K · filed 2019-03-27 | |||||||
| 2017-09-30 | 1.46M shares 10-Q · filed 2018-11-14 | 14.61M shares 10-Q · filed 2017-11-08 | ||||||
| 2017-06-30 | 1.48M shares 10-Q · filed 2018-08-14 | 14.76M shares 10-Q · filed 2017-08-10 | ||||||
| 2017-03-31 | 1.57M shares 10-Q · filed 2018-05-10 | 15.74M shares 10-Q · filed 2017-05-11 | ||||||
| 2016-12-31 | 2.08M shares 10-K · filed 2018-03-26 | 20.83M shares 10-K · filed 2017-03-30 | ||||||
| 2016-09-30 | 169.14K shares 10-Q/A · filed 2018-03-26 | 1.69M shares 10-Q · filed 2016-11-10 | ||||||
| 2016-06-30 | 294.69K shares 10-Q/A · filed 2018-03-26 | 2.95M shares 10-Q · filed 2016-08-11 | ||||||
| 2016-03-31 | 294.69K shares 10-Q/A · filed 2018-03-26 | 2.95M shares 10-Q · filed 2016-05-12 | ||||||
| 2015-12-31 | 2.89M shares 10-K · filed 2017-03-30 | 28.89M shares 10-K · filed 2016-03-30 | ||||||
| 2015-09-30 | 2.93M shares 10-Q · filed 2016-11-10 | 29.28M shares 10-Q · filed 2015-11-12 | ||||||
| 2015-06-30 | 2.93M shares 10-Q · filed 2016-08-11 | 29.30M shares 10-Q · filed 2015-08-12 | ||||||
| 2015-03-31 | 1.07M shares 10-Q · filed 2016-05-12 | 10.66M shares 10-Q · filed 2015-05-13 | ||||||
| 2014-12-31 | 19.31M shares 10-K · filed 2016-03-30 | |||||||
| 2014-09-30 | 19.74M shares 10-Q · filed 2015-11-12 | |||||||
| 2014-06-30 | 25.56M shares 10-Q · filed 2015-08-12 | |||||||
| 2014-03-31 | 25.67M shares 10-Q · filed 2015-05-13 | |||||||
| 2013-12-31 | 26.87M shares 10-K · filed 2015-03-30 | |||||||
| 2013-09-30 | 26.55M shares 10-Q · filed 2014-11-13 | |||||||
| 2013-06-30 | 26.37M shares 10-Q · filed 2014-08-14 | |||||||
| 2013-03-31 | 26.26M shares 10-Q · filed 2014-05-14 | 787.66M shares 10-Q · filed 2013-05-15 | ||||||
| 2012-12-31 | 25.84M shares 10-K · filed 2014-03-28 | 775.21M shares 10-K · filed 2013-03-29 | ||||||
| 2012-09-30 | 25.47M shares 10-Q · filed 2013-11-14 | 764.15M shares 10-Q · filed 2012-11-13 | ||||||
| 2012-06-30 | 25.08M shares 10-Q · filed 2013-08-14 | 752.37M shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |